CAM
MTEM

ClariVest Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

ClariVest Asset Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,593
Closed -$548K – 802
2022
Q1 		$548K Buy
10,593
+1,814
+21% +$80.1K 0.02% 372
2021
Q4 		$517K Buy
8,779
+2,732
+45% +$205K 0.02% 430
2021
Q3 		$609K Sell
6,047
-42
-0.7% -$4.33K 0.02% 411
2021
Q2 		$714K Buy
6,089
+3,447
+130% +$451K 0.02% 363
2021
Q1 		$500K Buy
2,642
+140
+6% +$24.5K 0.02% 414
2020
Q4 		$352K Buy
2,502
+440
+21% +$65K 0.01% 442
2020
Q3 		$338K Sell
2,062
-127
-6% -$22.6K 0.01% 405
2020
Q2 		$453K Sell
2,189
-133
-6% -$30.9K 0.01% 417
2020
Q1 		$463K Sell
2,322
-147
-6% -$32.2K 0.01% 407
2019
Q4 		$519K Buy
+2,469
New +$355K 0.01% 423

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClariVest Asset Management's MTEM Position: Q2 2022 in Review

ClariVest Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 10,593 shares — an estimated $548K sold.

ClariVest Asset Management first reported a position in MTEM in Q4 2019 and held it in 10 quarters. The position peaked at $714K in Q2 2021. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • ClariVest Asset Management reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 10,593 Molecular Templates, Inc. shares in Q2 2022, an estimated $548K.
  • ClariVest Asset Management first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 10 quarters.
  • ClariVest Asset Management's Molecular Templates, Inc. position peaked at $714K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on ClariVest Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.